Navigation Links
Cardium Presents Second Quarter 2012 Financial Results And Reports On Recent Developments
Date:8/14/2012

AP), we use a non-GAAP financial measure called non-GAAP earnings or loss per share. We define non-GAAP earnings or loss per share as net income or loss not including the impact of non-cash items: stock-based compensation and change in fair value of derivative liabilities.

It should be noted that basic and diluted weighted average shares are determined on a GAAP basis and the resulting share count is used for computing both GAAP and non-GAAP basic and diluted earnings per share.

With the adoption of ASC 815 and its very substantial impact on our total liabilities including certain non-cash derivative liabilities and corresponding reported net gains and losses arising from changes in the underlying market value of our common stock, we believe that non-GAAP earnings or loss per share provides meaningful supplemental information regarding our performance by excluding certain expenses that may not be indicative of the core business operating results and may help in comparing current-period results with those of prior periods as well as with our peers. We present this information to investors as an additional tool for evaluating our financial results in a manner that reflects ongoing operations and facilitates comparisons with operating results from prior periods.  The presentation of this additional non-GAAP information is intended to provide investors with additional incremental tools for their review of our results and is not meant to be considered in isolation or as a substitute for financial information presented in accordance with GAAP.

 


'/>"/>
SOURCE Cardium Therapeutics
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

Related medicine technology :

1. Cardium Announces Plans For Commercializaton Of Excellagen® In The Russian Federation
2. Cardium to Present at Sachs Associates 2012 Science, Partner, and Investment Forum: Gateway for the Global Life Sciences
3. Cardium Announces Agreement With UK-Based Angel Biomedical For Excellagen Supply And Planned European Market Expansion
4. Cardium Exhibiting Its New FDA-Cleared Excellagen® At The 2012 Spring Symposium Of Advanced Wound Care
5. Inovio Initiates H1N1 Universal Influenza Vaccine Clinical Trial Targeting Over-65 Population, Which Represents 90% of Flu Deaths
6. Grant & Eisenhofer Represents Key Whistleblower in Justice Dept.s $1.04 Billion Civil Settlement with GlaxoSmithKline
7. OncoSec Presents Preliminary Safety Data for Phase II Melanoma Study at Second European Post-Chicago Melanoma Meeting 2012
8. Abbott Presents Results of Clinical Studies Evaluating Its Investigational Treatment for Advanced Parkinsons Disease
9. Frost & Sullivan: Developing Integration Capabilities Presents a Real Opportunity for Vendors in the European CIS Market
10. This Week: UBM Canon Presents an Online Event and Conference Dedicated to Emerging Trends in Medical Device Outsourcing/Contract Manufacturing
11. Berg Pharma presents at ASCO, poised to lead field in cancer metabolism with Phase II trials of BPM 31510
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2015)... , April 28, 2015 /CNW/ - The group representing the ... drug tragedy left a two-hour meeting with Health Canada ... March 6th, Health Canada announced a $180 million support ... than six weeks after the Health Canada announcement and ... fully support the victims, the group representing ...
(Date:4/28/2015)... Israel , April 28, 2015 ... in its sixth funding cycle for U.S.- Israel ... and Energy Efficiency. To be considered, a project ... between a company and a university/research institution (one from the ... proposal should have significant commercial potential and the project outcome ...
(Date:4/27/2015)... Intarcia Therapeutics, Inc. today announced the closing of ... conversion option at a $5.5 billion Company valuation. Plans ... of additional head-to-head comparative and switch studies of ITCA ... therapies. In addition, proceeds from the financing will fund ... 650 in the United States , ...
Breaking Medicine Technology:Thalidomide Victims Gravely Concerned by Health Canada's Silence 2Opportunities for Funding U.S.-Israel Cooperation for Renewable Energy and Efficiency 2Intarcia Therapeutics Closes Novel $225 Million Synthetic Royalty Financing With Equity Conversion Option At $5.5 Billion Valuation 2Intarcia Therapeutics Closes Novel $225 Million Synthetic Royalty Financing With Equity Conversion Option At $5.5 Billion Valuation 3
... , , PITTSBURGH, Jan. 11 ... global, private High-Definition broadcasting network, has engineered a ... for world-renowned pharmaceutical and medical device companies. ... Novartis, Shire, Schering-Plough, Bristol-Myers Squib, Cardiovascular Research Foundation ...
... Maine, Jan. 11 IDEXX Laboratories, Inc. (Nasdaq: ... of 2,000 Catalyst Dx® chemistry analyzers in 2009, bringing ... in the first quarter of 2008, is a next ... integrated suite of analyzers and significantly expands the range ...
Cached Medicine Technology:VELOCITY Broadcasting Injects ROI into Pharmaceutical Sector by Engaging Medical Professionals with Experiential High-Definition Broadcast Events 2VELOCITY Broadcasting Injects ROI into Pharmaceutical Sector by Engaging Medical Professionals with Experiential High-Definition Broadcast Events 3IDEXX Laboratories Announces Catalyst Dx(R) Placement Total for 2009 and Installed Base of SmartService(TM) Customers 2
(Date:4/28/2015)... 2015 Georgia State University’s School of ... that will partner with the school on efforts to ... nation that produces more tobacco and has more smokers ... China Tobacco Control Partnership-Tobacco Free Cities, will focus on ... to support tobacco control efforts and where public health ...
(Date:4/28/2015)... 2015 Tools4ever, the market leader ... today that they have been chosen by IT ... Identity and Access Management vendors. IT Central Station ... and Access Management tools by real users in ... analyzed their trends to come up with the ...
(Date:4/28/2015)... 28, 2015 A new survey from ... lung damage, 66 percent of Americans fear brain damage the ... Awareness Month in May, shed light on the need for ... help prevent a stroke. By controlling modifiable risk factors, ... stroke is a “ brain attack ” that occurs when ...
(Date:4/28/2015)... April 28, 2015 A first-in-human ... of Molecular Imaging and Biology showed initial safety, ... generation fluorine-18 labeled small-molecule PSMA inhibitor. The imaging ... in Baltimore, MD by study co-author, Martin G. ... evaluation of [18F]DCFPyL demonstrated a number of important ...
(Date:4/28/2015)... Colorado spine surgeon Donald Corenman, MD, ... popular spine education website NECKANDBACK.COM and his ... Media. This website has been redesigned to help patients ... spine, causes of neck and back pain, and conditions ... and personally answers questions in the neck and back ...
Breaking Medicine News(10 mins):Health News:Georgia State Names Partner Cities For Tobacco Control Project 2Health News:Tools4ever Chosen as Part of “Top Identity and Access Management Tools - 2015 Edition” 2Health News:National Stroke Association Survey Reveals Americans Fear Brain Damage the Most, but Few Take the Necessary Steps to Prevent a Stroke 2Health News:National Stroke Association Survey Reveals Americans Fear Brain Damage the Most, but Few Take the Necessary Steps to Prevent a Stroke 3Health News:Second Generation 18F-labeled Prostate-Specific Membrane Antigen (PSMA) Targeted Imaging Agent Found to be Highly Sensitive in Detecting Prostate Cancer 2Health News:Second Generation 18F-labeled Prostate-Specific Membrane Antigen (PSMA) Targeted Imaging Agent Found to be Highly Sensitive in Detecting Prostate Cancer 3Health News:Colorado Spine Surgeon Donald Corenman, MD, DC Launches Updated Version of NECKANDBACK.COM and Popular Back Pain Forum ASKSPINEDOC.COM 2Health News:Colorado Spine Surgeon Donald Corenman, MD, DC Launches Updated Version of NECKANDBACK.COM and Popular Back Pain Forum ASKSPINEDOC.COM 3
... , ATLANTA, Nov. 30 Kool Smiles received ... one of InfoWorld ,s Top 100 IT ... Kool Smiles built a Wyse-based thin-client infrastructure to support the electronic ... States. With this roll-out now complete, Kool Smiles has implemented ...
... , , ... million people become infected with HIV, and two million die from ... Day 2009 the Global AIDS Alliance (GAA) calls on President Obama ... the World Health Organization (WHO) showing that the AIDS pandemic continues ...
... , SEATTLE, Nov. 30 Major League Baseball,s ... recently acquired by the Chicago White Sox, will receive the 2009 ... Baseball player who best exemplifies the honor, courage and dedication of ... , The 28-year-old Redlands, Calif., native made his MLB ...
... While recognizing significant impact, CBO analysis understates the ... The Blue Cross and Blue Shield Association (BCBSA) ... by the Congressional Budget Office (CBO): , The CBO ... experts have said for weeks: the Senate healthcare reform ...
... for lifelong residents of ,stroke belt, study finds ... in the "stroke belt" of the southern United States have ... even if they live elsewhere later, a new study shows. ... the North and South Carolina, Georgia, Tennessee, Arkansas, Mississippi and ...
... equivalent to 113 chest X-rays, study finds , MONDAY, Nov. ... have abdominal/pelvic CT scans receive additional unnecessary imaging tests that ... the study, 978 CT abdominal and pelvic series were performed ... of the patients were 30 to 50 years of age. ...
Cached Medicine News:Health News:Kool Smiles Named Among 2009 InfoWorld 100 2Health News:GAA Calls on President Obama to Act on the Reality of AIDS 2Health News:GAA Calls on President Obama to Act on the Reality of AIDS 3Health News:Mark Teahen Named 2009 Hutch Award Winner 2Health News:CBO Confirms That Premiums Will Increase Under the Senate Healthcare Reform Bill 2Health News:Birth in South Raises Stroke Risk for Life 2Health News:Birth in South Raises Stroke Risk for Life 3Health News:CT Scan Patients May Get Unnecessary Imaging 2
... 233 is an assayed quality ... the measurements of total hemoglobin ... instrumentation. It is available in ... analyzer performance at varying points ...
... is an assayed quality control material for blood ... four (4) levels for monitoring analyzer performance at ... be used on multiple test analyzers (such as ... 600). QC623 is also for use on ITC ...
... an assayed quality control material used ... gas, electrolyte, metabolite, and CO-Oximeter instrumentation. ... makes it the ideal choice for ... available in three (3) levels for ...
QC 123 is an assayed quality control material for blood gas instrumentation. It is available in three (3) levels for monitoring analyzer performance at varying points within the clinical range....
Medicine Products: